These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7589641

  • 21. The effects of nomegestrol acetate subdermal implant (Uniplant) on carbohydrate metabolism, serum lipoproteins and on hepatic function in women.
    Barbosa I, Coutinho E, Athayde C, Ladipo O, Olsson SE, Ulmsten U.
    Contraception; 1995 Aug; 52(2):111-4. PubMed ID: 8536447
    [Abstract] [Full Text] [Related]

  • 22. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J, Hassager C, Jensen SB, Riis BJ, Christiansen C.
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [Abstract] [Full Text] [Related]

  • 23. Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea.
    Grandi G, Napolitano A, Xholli A, Tirelli A, Di Carlo C, Cagnacci A.
    Gynecol Endocrinol; 2015 Oct; 31(10):774-8. PubMed ID: 26291811
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins.
    Haines CJ, Chung TK, Masarei JR, Tomlinson B, Lau JT.
    Atherosclerosis; 1996 Jan 26; 119(2):215-22. PubMed ID: 8808498
    [Abstract] [Full Text] [Related]

  • 27. An open-label study of subdermal implants of estradiol-only versus subdermal implants of estradiol plus nomegestrol acetate: effects on symptom control, lipid profile and tolerability.
    Barbosa IC, Coutinho EM, Oladapo L, Noronha CF, Mota RL, Lopes AC, Lopes RC.
    Gynecol Endocrinol; 2009 Apr 26; 25(4):269-75. PubMed ID: 19408176
    [Abstract] [Full Text] [Related]

  • 28. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS, Bäckström T, Haeger M, Jonsson B, Bixo M.
    Maturitas; 2004 Jun 15; 48(2):137-46. PubMed ID: 15172088
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.
    Lobo RA, Bush T, Carr BR, Pickar JH.
    Fertil Steril; 2001 Jul 15; 76(1):13-24. PubMed ID: 11438314
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Continuous combined and sequential estradiol and norethindrone acetate treatment of postmenopausal women: effect of plasma lipoproteins in a two-year placebo-controlled trial.
    Munk-Jensen N, Ulrich LG, Obel EB, Nielsen SP, Edwards D, Meinertz H.
    Am J Obstet Gynecol; 1994 Jul 15; 171(1):132-8. PubMed ID: 8030688
    [Abstract] [Full Text] [Related]

  • 33. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.
    Thromb Haemost; 2001 Apr 15; 85(4):619-25. PubMed ID: 11341495
    [Abstract] [Full Text] [Related]

  • 34. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K, Neuenschwander PF, Kurdowska AK.
    Int J Pharm Compd; 2013 Apr 15; 17(1):74-85. PubMed ID: 23627249
    [Abstract] [Full Text] [Related]

  • 35. Nomegestrol acetate and vascular reactivity: nonhuman primate experiments.
    Paris JM, Williams KJ, Hermsmeyer KR, Delansorne R.
    Steroids; 2000 Apr 15; 65(10-11):621-7. PubMed ID: 11108868
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
    Couzinet B, Young J, Kujas M, Meduri G, Brailly S, Thomas JL, Chanson P, Schaison G.
    J Clin Endocrinol Metab; 1999 Nov 15; 84(11):4191-6. PubMed ID: 10566671
    [Abstract] [Full Text] [Related]

  • 38. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T, Creatsas G, Rechberger T, Depypere H, Erenus M, Quail D, Arndt T, Bonnar J, Euralox 1 Study Group.
    Climacteric; 2001 Dec 15; 4(4):320-31. PubMed ID: 11770189
    [Abstract] [Full Text] [Related]

  • 39. Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity.
    Catherino WH, Jordan VC.
    J Steroid Biochem Mol Biol; 1995 Nov 15; 55(2):239-46. PubMed ID: 7495704
    [Abstract] [Full Text] [Related]

  • 40. [Effects of progesterone and nomegestrol acetate on the endometrial epithelium of the rabbit. A study with scanning electron microscopy].
    Paris JM, Mrena E, Lanquetin A, Marchal GM, Thévenot R.
    J Pharmacol; 1986 Nov 15; 17(4):508-14. PubMed ID: 3560966
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.